Custom Assays

Our technology platform fully integrates DNA collection, extraction and analysis, with an intuitive interface that is easy to operate.

We're taking what we've learned through thirteen years of research and development and applying it to new diverse fields such as environmental testing, veterinary diagnostics, and food testing.

Using Spartan's technology, end users receive test results in a fraction of the time compared to traditional lab-based testing. It's on-site, lab quality DNA testing in the palm of your hand.

Do you have a problem that needs a Spartan solution?

Evidence

Accuracy and precision of Legionella isolation by US laboratories in the ELITE program pilot study

Environmental
  • The CDC conducted a proficiency study of 20 ELITE-certified Legionella culture testing labs.
  • On average, the culture labs undercounted actual Legionella concentrations by 17-fold and values differed between labs by 6-fold.
Read the full study

Validation and in-field testing of a new on-site qPCR system for quantification of Legionella pneumophila according to ISO/TS 12869:2012 in HVAC cooling towers

Environmental
  • 53 cooling towers were tested for 12 weeks by Spartan's on-site qPCR test and lab culture.
  • On-site qPCR detected Legionella above the acceptable limit of 10 bacteria/mL in 21 towers (40%).
  • In contrast, lab culture only detected Legionella above the limit in 8 towers (15%), and completely missed a tower with contamination >100× the limit.
  • A major reason for culture's poor performance was that bacteria degraded in 72% of water samples shipped to the lab.
  • Lab qPCR showed no correlation with lab culture and suffered the same bacterial degradation effect during shipping.
  • 11 cooling towers (21%) experienced rapid Legionella growth of 3X to 21X over 7 days.
  • Spartan's on-site Legionella qPCR test was validated according to ISO 12869 and detects live not dead bacteria.
Read the full study

Precision Medicine at the University of Alabama at Birmingham: Laying the foundational processes through implementation of Genotype-Guided Antiplatelet Therapy

Medical
  • This independent report describes concordance of the Spartan RX with gold standard genotyping.

The use described in this publication is not approved or cleared by the US FDA. This study was supported in part by University of Alabama at Birmingham's Health Service Foundations' General Endowment Fund; The Hugh Kaul Precision Medicine Institute; by grants from the National Institutes of Health (grant numbers RO1HL092173, K24HL133373 to N.L.); and the National Human Genome Research Institute of the National Institutes of Health (grant number T32HG008961 to B.D.). Spartan knows of no other financial interests. Spartan knows of no significant risks or safety concerns associated with the use described in this publication.

Read the full study
View all evidence